RE: 2 employees onlyJERUSALEM, February 15, 2011 -- Medisafe 1 Technologies Corp. (OTCBB:MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, has been contacted over the past few weeks by several global medical technology companies for potential cooperation.
For these companies, that have strong leadership in developing, manufacturing and selling medical supplies, devices, laboratory instruments, and diagnostic products to the US and global healthcare market, Medisafe's proprietary locking devices would be a valuable and complementary addition to their existing product range.
"The current discussions focus on how our patented product concept and technology could benefit our potential partners," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "We are also discussing our mutual goals and areas of interests for potential cooperation. We will inform our shareholders within a few weeks of our progress."
Medisafe 1 Technologies' patented syringe locking device helps to reduce the number of injuries and deaths related to improper administration of medications.